Application 217026

Type
NDA
Sponsor
ACADIA PHARMS INC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001DAYBUETROFINETIDESOLUTION;ORAL200MG/MLYesYes

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
85605SUPPL 2026-03-31
85573SUPPL 2026-03-30
83130SUPPL 2025-08-19
83129SUPPL 2025-08-19
83056SUPPL 2025-08-06
83055SUPPL 2025-08-06
79798SUPPL 2024-10-03
79799SUPPL 2024-10-02
79787SUPPL 2024-10-01
79786SUPPL 2024-10-01
73952ORIG 2023-04-06
73740ORIG 2023-03-30
73738ORIG 2023-03-13